← All stocks

Steris

STE Scheduled selling only
CIK 0001757898 #422 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$9.87M
$1.28M on a plan · $8.59M straight out of an exercise
Sold at will
$0.00
0 of 13 sales
Net
−$9.87M
$0.00 against sales at will

By person

13 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Zangerle John Adam
Sr. VP, Gen Counsel, and Sec.
$4.27M (2) scheduled
−$4.27M
35,259
0.0361%
$8.31M
+5.7%
Madsen Julia
Sr. VP and GM, Life Sciences
$1.31M (2) scheduled
−$1.31M
12,257
0.0126%
$2.89M
+26.7%
Tamaro Renato
V.P. & Corporate Treasurer
$1.30M (3) scheduled
−$1.30M
6,194
0.0063%
$1.46M
−10.0%
Carestio Daniel A
President and CEO
$985.25K (3) scheduled
−$985.25K
63,647
0.0652%
$15.01M
+13.0%
Sohi Mohsen
Director
$956.80K (1) scheduled
−$956.80K
24,305
0.0249%
$5.73M
+8.7%
FELDMANN CYNTHIA L
Director
$734.88K (1) scheduled
−$734.88K
705
0.0007%
$166.22K
0.0%
Breeden Richard C
Director
$310.28K (1) scheduled
−$310.28K
38,964
0.0399%
$9.19M
+19.7%
TOKICH MICHAEL J
Sr. Vice Pres., CFO
43,891
0.0450%
$10.35M
+2.2%
Majors Cary L
SVP and President, Healthcare
17,338
0.0178%
$4.09M
+32.8%
Fraser Mary Clare
SVP & Chief HRO
13,716
0.0141%
$3.23M
+23.2%
Burton Karen L
Sr. Vice Pres., CFO
13,184
0.0135%
$3.11M
+200.5%
Kohler Kenneth E
SVP & GM, AST
11,332
0.0116%
$2.67M
+39.5%
McGowan Lindsey
VP, Chf. Comp. & Quality Offc.
5,656
0.0058%
$1.33M
+33.7%
Insider
Date
Role
Action
Shares
Price
Amount
Sohi Mohsen
12 Aug 2026
Director
Sold after exercise
4,058
$235.78
$956.80K
Sohi Mohsen
1 Jul 2026
Director
Exercised, kept
3,781
$71.40
$269.96K
Zangerle John Adam
15 Jun 2026
Sr. VP, Gen Counsel, and Sec.
Sold on a plan
1,419
$209.28
$296.97K
Carestio Daniel A
5 Jun 2026
President and CEO
Sold on a plan
1,374
$212.00
$291.29K
Carestio Daniel A
4 Jun 2026
President and CEO
Sold on a plan
3,054
$214.64
$655.51K
Breeden Richard C
2 Jun 2026
Director
Sold after exercise
1,481
$209.51
$310.28K
FELDMANN CYNTHIA L
5 Mar 2026
Director
Sold after exercise
3,098
$237.21
$734.88K
Madsen Julia
21 Nov 2025
Sr. VP and GM, Life Sciences
Sold after exercise
2,136
$262.00
$559.63K
Madsen Julia
21 Nov 2025
Sr. VP and GM, Life Sciences
Sold after exercise
2,872
$262.00
$752.46K
Tamaro Renato
18 Nov 2025
V.P. & Corporate Treasurer
Sold after exercise
1,500
$257.76
$386.64K
Tamaro Renato
18 Nov 2025
V.P. & Corporate Treasurer
Sold after exercise
212
$258.03
$54.70K
Tamaro Renato
18 Nov 2025
V.P. & Corporate Treasurer
Sold after exercise
3,324
$257.43
$855.70K
Zangerle John Adam
11 Nov 2025
Sr. VP, Gen Counsel, and Sec.
Sold after exercise
15,000
$265.14
$3.98M
Carestio Daniel A
6 Oct 2025
President and CEO
Sold on a plan
159
$241.82
$38.45K

What was left out

Form 4 filings counted 57
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 9
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 105,307
History held since 28 Mar 2019